LINC01432 binds to CELF2 in newly diagnosed multiple myeloma promoting short progression-free survival to standard therapy
Richa Mishra, Prasanth Thunuguntla, Dhanusha Duraiyan, Alani Perkin, Katelyn Bagwill, Savannah Gonzales, Catheryn Sizemore, Vanessa Brizuela, Jaiyana King, Stephen Daly, Yoon Jae Chang, Mahdote Abebe, Yash Rajana, Kelly Wichmann, Christ Enyan, , Jessica Silva-Fisher
This study identifies LINC01432 as a lncRNA that binds to CELF2 and inhibits apoptosis in multiple myeloma, contributing to short progression-free survival to standard therapy.
Oncogenesis · Oct 6, 2025Peer-reviewedCancer Biology